Clinical Trial

γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

Name: γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma — clinical trial record (NCT07172178)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This study intends to combine the advantages of γδ T cells and PD-1 monoclonal antibody to conduct an exploratory clinical study on the safety and efficacy of PD-1 antibody armored γδ T cells (γδ T-PD-1 Ab cells) in the treatment of malignant meningioma.

Trial Details

NCT Number	NCT07172178
Lead Sponsor	Nanjing Medical University
Conditions	Malignant Meningioma
Enrollment	12 participants
Start Date	2025-10-15
Primary Completion	2028-10 (estimated)
Study Completion	2029-10 (estimated)
Updated on ClinicalTrials.gov	2025-09-15